Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-12-12

Clinical Trial Update: The Role of microRNA-29b in the Oral Squamous Cell Carcinoma

View source ↗

Summary

An update on a clinical trial examining the role of microRNA-29b in oral squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • microRNA-29b (miR-29b)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Oral Cancer | Status: UNKNOWN